Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing
Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)
Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377